[Antitubercular therapeutic regimens routinely prescribed in Bas-Rhin and results of treatment].
The overall plans and therapeutic regimens prescribed for new cases of pulmonary tuberculosis notified in the Bas-Rhin in 1979 to 1980 (372 Subjects) were studied, as were relapses occurring over a three year period from the date of notification. As in the preceding analysis of cases between 1970/78, the proportion of patients treated exclusively at home was low (22.8%) and the duration of stay in a Sanatorium was lengthy (mean 86.6 days for cases without bacteriological confirmation and 142.3 days for bacteriologically positive cases). The mean duration of chemotherapy was 12.5 months (+/- 3.7). The therapeutic regimens prescribed showed a significant variability: if 80.6% of patients received, at one time or another, the combination of Isoniazid (H), Rifampicin (R) and Ethambutol (E), only 33.9% of the adults treated received the HRE/HR regimen, for periods of variable duration. Four relapses were seen during the fixed follow-up period.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000553:Ambulatory Care; D000995:Antitubercular Agents / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D005602:France; D006760:Hospitalization; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012293:Rifampin / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology
D000995:Antitubercular Agents; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
Régimes thérapeutiques antituberculeux prescrits en routine dans le Bas-Rhin et résultats du traitement.